INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.

The effect of the polymorphism in IL-28B gene on the treatment response of a combined therapy by sofosbuvir and daclatasvir with and without ribavirin in HCV Egyptian patients

Interferon-Lambda 4 Gene Polymorphisms Predict Treatment Response in Egyptian HCV Genotype 4 Patients Exposed to Radiation

Interleukin 28 B genotype as a predictor of response to therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients

Interleukin 28b Single Nucleotide Polymorphism (rs8099917) as a Predictive Factor of Response to Pegylated-IFN/Ribavirintherapy in Chronic HCV Patients

INTERLEUKIN-6 (-597G/A) POLYMORPHISM IN EGYPTIAN HEPATITIS C-VIRUS INFECTED PATIENTS

IMPACT OF INTERLEUKIN-28 B (rs12979860) GENE POLYMORPHISM ON INTRAFAMILIAL TRANSMISSION OF HCV IN EGYPT.

The relation between interleukin 28B gene polymorphisms (rs8099917 and rs12980275) and the response of treatment of Hepatitis C Virus genotype 4 patients to Sofosbuvir and Daclat

Interferon-Gamma Inducible Protein-10(IP10) as a Predictor of Early Virologic Response in Chronic Hepatitis C Infected Egyptian Patients Stratified for the Interleukin-28B rs12979

The Role of Interleukin-10 Gene Polymorphism in Egyptian Patients with Chronic Hepatitis C Virus